VCEL Vericel Corp

Price (delayed)

$46.64

Market cap

$2.38B

P/E Ratio

108.47

Dividend/share

N/A

EPS

$0.43

Enterprise value

$2.37B

?
Relative Growth: Rel. Growth: 93
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: 43
Relative Profitability: Rel. Profitability: 74

Vericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured ...

Highlights
The EPS has grown by 30% from the previous quarter
The net income is up by 30% QoQ

Key stats

What are the main financial stats of VCEL

VCEL stock price

How has the Vericel stock price performed over time
Intraday
-2.45%
1 week
-0.77%
1 month
19.19%
1 year
28.63%
YTD
29.52%
QTD
4.83%

Financial performance

How have Vericel's revenue and profit performed over time
Revenue
$292.09M
Gross profit
$218.59M
Operating income
$15.77M
Net income
$21.46M
Gross margin
74.8%
Net margin
7.3%
Vericel's operating income has increased by 43% QoQ
Vericel's operating margin has increased by 35% from the previous quarter
The net income is up by 30% QoQ
The gross profit has grown by 26% YoY and by 6% from the previous quarter

Price vs fundamentals

How does VCEL's price correlate with its fundamentals

Growth

What is Vericel's growth rate over time

Valuation

What is Vericel stock price valuation
P/E
108.47
P/B
6.65
P/S
8.11
EV/EBIT
103.1
EV/EBITDA
58.56
EV/Sales
8.1
The EPS has grown by 30% from the previous quarter
The stock's P/E is 27% less than its last 4 quarters average of 152.2
VCEL's price to book (P/B) is 26% higher than its last 4 quarters average of 5.4 but 16% lower than its 5-year quarterly average of 8.1
The equity rose by 21% year-on-year
VCEL's price to sales (P/S) is 24% higher than its last 4 quarters average of 6.7 but 10% lower than its 5-year quarterly average of 9.2
The revenue has grown by 22% YoY and by 6% from the previous quarter

Efficiency

How efficient is Vericel business performance
The ROIC is up by 25% since the previous quarter
Vericel's return on assets has increased by 24% QoQ
VCEL's ROE is up by 23% from the previous quarter
The ROS has grown by 22% from the previous quarter

Dividends

What is VCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VCEL.

Financial health

How did Vericel financials performed over time
The total assets has increased by 14% YoY
The quick ratio has increased by 6% year-on-year and by 2.2% since the previous quarter
The debt is 73% lower than the equity
The equity rose by 21% year-on-year
Vericel's debt to equity has decreased by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.